Gamma‐glutamyltranspeptidase levels as an aid in the management of human cancer

Plasma gamma‐glutamyltranspeptidase (GGTP) levels were measured in 435 cancer patients, 120 healthy controls, 15 patients with systemic lupus erythematosis, and 10 patients with rheumatoid arthritis. The mean GGTP activity of all cancer patients studied, with the exception of malignant lymphoma, was significantly elevated compared to control values. Several patient groups were retrospectively analyzed to determine whether GGTP levels correlated with clinical status. Patients who were disease‐free had GGTP levels in the normal range, whereas patients with metastases had elevated levels. Serially increasing GGTP levels were associated with disease progression and death. Persons who remained free of disease had serial GGTP levels within the normal range. Furthermore, decreasing levels were associated with response to therapy. These results indicate that GGTP levels may have prognostic value in various human malignancies.

[1]  R. Nordquist,et al.  Elevated γ‐glutamyl transpeptidase levels in malignant melanoma , 1982 .

[2]  T. Powles,et al.  Screening for metastases in breast cancer: An assessment of biochemical and physical methods , 1981, Cancer.

[3]  J. Barlow,et al.  Evaluation of 5′‐nucleotidase as an enzyme marker in ovarian carcinoma , 1981, Cancer.

[4]  R. Thompson,et al.  RADIOIMMUNOASSAY OF SERUM CREATINE KINASE-BB AS A TUMOUR MARKER IN BREAST CANCER , 1980, The Lancet.

[5]  J. H. Shaper,et al.  Serum UDP‐galactosyl transferase as a potential biomarker for breast carcinoma , 1980, Journal of surgical oncology.

[6]  C. Ip,et al.  Serum sialyltransferase and 5'-nucleotidase as reliable biomarkers in women with breast cancer. , 1980, Journal of the National Cancer Institute.

[7]  Yeu‐Tsu N. Lee,et al.  Plasma sialyltransferase in patients with breast cancer , 1980, Journal of surgical oncology.

[8]  T. Powles,et al.  ASSESSMENT OF BIOCHEMICAL TESTS TO SCREEN FOR METASTASES IN PATIENTS WITH BREAST CANCER , 1980, The Lancet.

[9]  A. Meister,et al.  Transport of gamma-glutamyl amino acids: role of glutathione and gamma-glutamyl transpeptidase. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[10]  F. A. Salinas,et al.  Serum sialic acid and sialyltransferase as monitors of tumor burden in malignant melanoma patients. , 1979, Cancer research.

[11]  G. Smith,et al.  γ-Glutamyltransferase in human and mouse breast tumours , 1979 .

[12]  E. Fiala,et al.  INCREASED γ-GLUTAMYL TRANSFERASE ACTIVITY IN HUMAN COLON CANCER , 1979, The Lancet.

[13]  S. Goldfarb,et al.  gamma-Glutamyl transpeptidase and malignant transformation of cultured liver cells. , 1979, Cancer research.

[14]  R. Boutwell,et al.  Localization and Significance of γ-Glutamyltranspeptidase in Normal and Neoplastic Mouse Skin , 1978 .

[15]  Shirley V. Y. Cheng,et al.  γ‐Glutamyltranspeptidase activity in normal, regenerating and malignant hepatocytes , 1978, FEBS letters.

[16]  M. Ross,et al.  Human kidney gamma-glutamyl transpeptidase. Catalytic properties, subunit structure, and localization of the gamma-glutamyl binding site on the light subunit. , 1977, The Journal of biological chemistry.

[17]  D. Kessel,et al.  Alterations in plasma sialyltransferase levels in patients with neoplastic disease , 1977, Cancer.

[18]  D. Kessel,et al.  Elevated plasma sialyltransferase in the cancer patient. , 1975, Cancer research.

[19]  S. Rosalki.  Gamma-glutamyl transpeptidase. , 1975, Advances in clinical chemistry.

[20]  Ali Ms.  Letter: Geriatric medicine. , 1974, Lancet.

[21]  Z. Albert.  Gamma-glutamyl Transpeptidase in Cancers of Different Human Organs , 1965, Nature.

[22]  M. Orłowski,et al.  Serum γ-Glutamyl Transpeptidase Activity in Liver Disease , 1961 .